Skip Navigation

Annals of Oncology 2007 18(8):1422-1423; doi:10.1093/annonc/mdm371
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow E-letters: View responses
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Torresin, A
Right arrow Articles by Cassola, G
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Torresin, A
Right arrow Articles by Cassola, G
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 2007 European Society for Medical Oncology

letters to the editor

Lymphoma and human immunodeficiency virus (HIV) infection: another favourable setting?

The first 10% of the full text of this article appears below.

In his editorial ‘The treatment of lymphoma complicating autoimmune disease: two birds with one stone?’ T. R. Mikuls states that subjects with rheumatoid arthritis (RA) and non-Hodgkin's lymphoma (NHL) fare better than non-RA patients with NHL, as far as response to therapy is concerned [1, 2]. . . . [Full Text of this Article]

A Torresin, M Feasi* and G Cassola

Infectious Diseases Department, E. O. Ospedali Galliera, Genova, Italy

* E-mail: marcello.feasi@galliera.it


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


E-letters:

Read all E-letters

Lymphoma and human immunodeficiency virus infection: why are outcomes improving?
Matthew C Cheung
Annals of Oncology, 13 Aug 2007 [Full text]